|
Volumn 4, Issue 3, 2005, Pages 121-126
|
The rate control, anticoagulation therapy, and electrophysiology/ antiarrhythmic medication pathway for the management of atrial fibrillation and atrial flutter
|
Author keywords
Atrial fibrillation; Atrial flutter; Clinical guidelines; Pathway; Risk stratification
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMIODARONE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIGOXIN;
DILTIAZEM;
DOFETILIDE;
ESMOLOL;
FLECAINIDE;
METOPROLOL;
PROPAFENONE;
SOTALOL;
VERAPAMIL;
WARFARIN;
ANTICOAGULANT THERAPY;
HEART ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HEART ATRIUM FLUTTER;
HEART ELECTROPHYSIOLOGY;
HEART RHYTHM;
HUMAN;
MEDICAL SOCIETY;
OPTIMAL DRUG DOSE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
|
EID: 24944498841
PISSN: 1535282X
EISSN: None
Source Type: Journal
DOI: 10.1097/01.hpc.0000174914.89013.4b Document Type: Review |
Times cited : (6)
|
References (6)
|